<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
>

<channel>
	<title>WMTC - West Midlands Training Course &#187; 2008</title>
	<atom:link href="http://www.wmtc.org.uk/category/past-exam-papers/2008/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.wmtc.org.uk</link>
	<description>West Midlands Training Course</description>
	<lastBuildDate>Thu, 09 Sep 2010 08:10:48 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=abc</generator>
<!-- podcast_generator="Blubrry PowerPress/1.0.9" mode="advanced" entry="normal" -->
	<itunes:summary>West Midlands Training Course</itunes:summary>
	<itunes:author>WMTC - West Midlands Training Course</itunes:author>
	<itunes:explicit>no</itunes:explicit>
	<itunes:image href="http://www.wmtc.org.uk/wp-content/plugins/powerpress/itunes_default.jpg" />
	<itunes:subtitle>West Midlands Training Course</itunes:subtitle>
	<image>
		<title>WMTC - West Midlands Training Course &#187; 2008</title>
		<url>http://www.wmtc.org.uk/wp-content/plugins/powerpress/rss_default.jpg</url>
		<link>http://www.wmtc.org.uk/category/past-exam-papers/2008/</link>
	</image>
		<item>
		<title>Short Answer Questions</title>
		<link>http://www.wmtc.org.uk/2010/03/short-answer-questions-2/</link>
		<comments>http://www.wmtc.org.uk/2010/03/short-answer-questions-2/#comments</comments>
		<pubDate>Thu, 11 Mar 2010 23:05:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[1999]]></category>
		<category><![CDATA[2000]]></category>
		<category><![CDATA[2001]]></category>
		<category><![CDATA[2002]]></category>
		<category><![CDATA[2003]]></category>
		<category><![CDATA[2004]]></category>
		<category><![CDATA[2005]]></category>
		<category><![CDATA[2006]]></category>
		<category><![CDATA[2007]]></category>
		<category><![CDATA[2008]]></category>
		<category><![CDATA[2009]]></category>
		<category><![CDATA[Past Exam Papers]]></category>
		<category><![CDATA[Short Answers]]></category>

		<guid isPermaLink="false">http://www.wmtc.org.uk/?p=792</guid>
		<description><![CDATA[Short Answer Questions below are links to all the short answer question papers that have been archived. Short Answers December 1999 Short Answers Summer 2000 Short Answers Spring 2000 Short Answers Spring 2000 Short Answers December 2000 Short Answers Spring 2001 Short Answers Summer 2001 Short Answers Summer 2001 Short Answers Spring 2002 Short Answers [...]]]></description>
			<content:encoded><![CDATA[<h2>Short Answer Questions</h2>
<p>below are links to all the short answer question papers that have been archived.</p>
<ul>
<li><a href="../wp-content/uploads/2010/03/shortanswersdecember1999.pdf">Short Answers December 1999</a></li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2010/03/shortanswerssummer2000.pdf">Short Answers Summer 2000</a></li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2010/03/shortanswersspring2000.pdf">Short Answers Spring 2000</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersspring2000.pdf">Short Answers Spring 2000</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersdecember2000.pdf">Short Answers December 2000</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswerssprin2001.pdf">Short Answers Spring 2001</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswerssummer2001.pdf">Short Answers Summer 2001</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersjuly2001.pdf">Short Answers Summer 2001</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswerssprin2002.pdf">Short Answers Spring 2002</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswerssummer2002.pdf">Short Answers Summer 2002</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswerssummer2002.pdf">Short Answers Summer 2002</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersautumn2002.pdf">Short Answers Autumn 2002</a></li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2010/03/shortanswerssummer2003.pdf">Short Answers Summer 2003</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersautumn2003.pdf">Short Answers Autumn 2003</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersmarch2004.pdf">Short Answer Spring 2004</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersmarch20041.pdf">Short Answers Spring 2004</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersdecember2004.pdf">Short Answers December 2004</a></li>
<li><a href="../wp-content/uploads/2010/03/shortanswersspring2005.pdf">Short Answers Spring 2005</a></li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2010/03/shortanswersspring2005.pdf">Short Answers Spring 2005</a></li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2010/03/shortanswersmarch2005.pdf">Short Answers Spring 2005</a></li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2010/03/shortanswersdecember20051.pdf">Short Answers Winter 2005</a></li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2010/03/shortanswersdecember2005.pdf">Short Answers December 2005</a></li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2010/03/shortanswerjune2007.pdf">Short Answers June 2007</a></li>
</ul>
<div class="lightsocial_container"><a class="lightsocial_a" href="http://digg.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F&amp;title=Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/digg.png" alt="Digg This" title="Digg This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.reddit.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F&amp;title=Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/reddit.png" alt="Reddit This" title="Reddit This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F&amp;title=Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/stumbleupon.png" alt="Stumble Now!" title="Stumble Now!" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://buzz.yahoo.com/buzz?targetUrl=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F&amp;headline=Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/yahoo_buzz.png" alt="Buzz This" title="Buzz This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dzone.com/links/add.html?title=Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dzone.png" alt="Vote on DZone" title="Vote on DZone" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.facebook.com/sharer.php?t=Short+Answer+Questions&amp;u=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/facebook.png" alt="Share on Facebook" title="Share on Facebook" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://delicious.com/save?title=Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/delicious.png" alt="Bookmark this on Delicious" title="Bookmark this on Delicious" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dotnetkicks.com/kick/?title=Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetkicks.png" alt="Kick It on DotNetKicks.com" title="Kick It on DotNetKicks.com" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://dotnetshoutout.com/Submit?title=Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetshoutout.png" alt="Shout it" title="Shout it" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F&amp;title=Short+Answer+Questions&amp;summary=&amp;source=" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/linkedin.png" alt="Share on LinkedIn" title="Share on LinkedIn" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.technorati.com/faves?add=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/technorati.png" alt="Bookmark this on Technorati" title="Bookmark this on Technorati" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://twitter.com/home?status=Reading+http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/twitter.png" alt="Post on Twitter" title="Post on Twitter" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.google.com/buzz/post?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2010%2F03%2Fshort-answer-questions-2%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/google_buzz.png" alt="Google Buzz (aka. Google Reader)" title="Google Buzz (aka. Google Reader)" /></a>&nbsp;&nbsp;</div>]]></content:encoded>
			<wfw:commentRss>http://www.wmtc.org.uk/2010/03/short-answer-questions-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Autumn 2008 &#8211; Exam Papers and Model Answers</title>
		<link>http://www.wmtc.org.uk/2009/01/autumn-2008-exam-papers-and-model-answers/</link>
		<comments>http://www.wmtc.org.uk/2009/01/autumn-2008-exam-papers-and-model-answers/#comments</comments>
		<pubDate>Sun, 11 Jan 2009 21:05:38 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[2008]]></category>
		<category><![CDATA[Past Exam Papers]]></category>
		<category><![CDATA[Spring 2008]]></category>
		<category><![CDATA[autumn]]></category>
		<category><![CDATA[essays]]></category>
		<category><![CDATA[exams]]></category>
		<category><![CDATA[model answers]]></category>

		<guid isPermaLink="false">http://www.wmtc.org.uk/?p=285</guid>
		<description><![CDATA[The autumn 2008 exam papers and model answers can be found here: Essay Questions Autumn 2008 Cholesterol Methods Model Answer Short Answer Questions Autumn 2008 Short Answer Questions Autumn 2008 &#8211; Model Answers]]></description>
			<content:encoded><![CDATA[<p>The autumn 2008 exam papers and model answers can be found here:</p>
<ul>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2009/01/examsessayautumn08.pdf">Essay Questions Autumn 2008</a>
<ul>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2009/01/cholesterol-methods.pdf">Cholesterol Methods Model Answer</a></li>
</ul>
</li>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2009/01/examssaqautumn08.pdf">Short Answer Questions Autumn 2008</a>
<ul>
<li><a href="http://www.wmtc.org.uk/wp-content/uploads/2009/04/examssaqmodelautumn08-1.pdf">Short Answer Questions Autumn 2008 &#8211; Model Answers</a></li>
</ul>
</li>
</ul>
<div class="lightsocial_container"><a class="lightsocial_a" href="http://digg.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F&amp;title=Autumn+2008+-+Exam+Papers+and+Model+Answers" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/digg.png" alt="Digg This" title="Digg This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.reddit.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F&amp;title=Autumn+2008+-+Exam+Papers+and+Model+Answers" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/reddit.png" alt="Reddit This" title="Reddit This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F&amp;title=Autumn+2008+-+Exam+Papers+and+Model+Answers" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/stumbleupon.png" alt="Stumble Now!" title="Stumble Now!" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://buzz.yahoo.com/buzz?targetUrl=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F&amp;headline=Autumn+2008+-+Exam+Papers+and+Model+Answers" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/yahoo_buzz.png" alt="Buzz This" title="Buzz This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dzone.com/links/add.html?title=Autumn+2008+-+Exam+Papers+and+Model+Answers&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dzone.png" alt="Vote on DZone" title="Vote on DZone" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.facebook.com/sharer.php?t=Autumn+2008+-+Exam+Papers+and+Model+Answers&amp;u=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/facebook.png" alt="Share on Facebook" title="Share on Facebook" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://delicious.com/save?title=Autumn+2008+-+Exam+Papers+and+Model+Answers&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/delicious.png" alt="Bookmark this on Delicious" title="Bookmark this on Delicious" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dotnetkicks.com/kick/?title=Autumn+2008+-+Exam+Papers+and+Model+Answers&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetkicks.png" alt="Kick It on DotNetKicks.com" title="Kick It on DotNetKicks.com" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://dotnetshoutout.com/Submit?title=Autumn+2008+-+Exam+Papers+and+Model+Answers&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetshoutout.png" alt="Shout it" title="Shout it" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F&amp;title=Autumn+2008+-+Exam+Papers+and+Model+Answers&amp;summary=&amp;source=" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/linkedin.png" alt="Share on LinkedIn" title="Share on LinkedIn" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.technorati.com/faves?add=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/technorati.png" alt="Bookmark this on Technorati" title="Bookmark this on Technorati" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://twitter.com/home?status=Reading+http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/twitter.png" alt="Post on Twitter" title="Post on Twitter" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.google.com/buzz/post?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2009%2F01%2Fautumn-2008-exam-papers-and-model-answers%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/google_buzz.png" alt="Google Buzz (aka. Google Reader)" title="Google Buzz (aka. Google Reader)" /></a>&nbsp;&nbsp;</div>]]></content:encoded>
			<wfw:commentRss>http://www.wmtc.org.uk/2009/01/autumn-2008-exam-papers-and-model-answers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Spring 2008 &#8211; Short Answer Questions</title>
		<link>http://www.wmtc.org.uk/2008/09/spring-2008-short-answer-questions/</link>
		<comments>http://www.wmtc.org.uk/2008/09/spring-2008-short-answer-questions/#comments</comments>
		<pubDate>Mon, 22 Sep 2008 20:09:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[2008]]></category>
		<category><![CDATA[Past Exam Papers]]></category>

		<guid isPermaLink="false">http://www.wmtc.org.uk/?p=159</guid>
		<description><![CDATA[Course Assessment – Spring 2008 Short Answer Questions. Answer all questions. Time allowed 1 hour 1. What is the absorbance of a 1cm pathlength of acetonitrile at 200nm when the percentage transmission is 80%? 10 marks 2. Define 1 unit of enzyme activity 10 marks 3. List five biochemical abnormalities associated with rhabdomyolysis. 2marks each [...]]]></description>
			<content:encoded><![CDATA[<h2>Course Assessment – Spring 2008</h2>
<p>Short Answer Questions.  Answer all questions.  Time allowed 1 hour</p>
<h3>1.	What is the absorbance of a 1cm pathlength of acetonitrile at 200nm when the percentage transmission is 80%?				10 marks</h3>
<h3>2.	Define 1 unit of enzyme activity				10 marks</h3>
<h3>3.	List five biochemical abnormalities associated with rhabdomyolysis.  2marks each</h3>
<h3>4.	A 70 kg man with severe hypomagnesaemia requires 24 mmol of magnesium intravenously.</h3>
<h4><span style="font-weight: normal;">a</span>.	What volume of solution containing 0.48g/2mL of anhydrous magnesium sulphate would be needed ? (Atomic Weights Mg = 24, S=32)							5 marks</h4>
<h4>b.	What is the final calculated osmolarity of the solution if this volume is added to 500 mL of 0.9% w/v sodium chloride?    	5 marks</h4>
<h3>5.	A new screening test has been developed to detect a tumour with a prevalence of 1 in 5000 of the population.  It has a diagnostic sensitivity of 95% and a specificity of 97%.</h3>
<h4>a.	Calculate the diagnostic efficiency of the test		5 marks</h4>
<h4>b.	Calculate the negative predictive value of the test           5 marks</h4>
<h3>6.	A 22 year old painter and decorator presented to his GP with a 2 week history of lethargy, malaise, headaches, nausea and cramping abdominal pain.  Blood results were as follows</h3>
<p>Na 140 mmol/L<br />
K 4.2 mmol/L<br />
U 5.6 mmol/L<br />
Cre 103 umol/L<br />
Alb 40 g/L<br />
ALT 24 U/L<br />
ALP 88 U/L<br />
Bili 6 umol/L<br />
Hb 9.4 g/L<br />
MCV 92 fl<br />
WCC 13.2 x109 L-1<br />
Platelets 231 x109 L-1</p>
<p>Basophilic stippling of erythrocytes was noted on the blood film.</p>
<h4><span style="font-weight: normal;">a</span>.	What is the most likely diagnosis?   		4 marks</h4>
<h4>b.	What is the mechanism behind the abnormal blood results?	3 marks</h4>
<h4>c.	What management/treatment options are available?				3 marks</h4>
<h3>7.	A paper describing the use of a new tumour marker included the following data relating to the concentrations of histologically proven disease:-</h3>
<p>Number of diseased patients (n) = 110<br />
Mean concentration of tumour marker = 80 U/L<br />
Standard error of mean = 5.5</p>
<h4><span style="font-weight: normal;">a</span>.	Calculate the standard deviation of the mean			5 marks</h4>
<h4>b.	If the reference interval for the tumour marker in non-diseased subjects is 10-15 U/L what can you conclude about the distribution of data in the diseased patients in this study? 5 marks</h4>
<h3>8.	One serum and one urine sample collected from a patient for the measurement of creatinine clearance were each assayed 10 times with the following results:-</h3>
<p>Urine Creatinine		Serum Creatinine<br />
mmol/L			umol/L</p>
<p>11.1			102<br />
11.5			108<br />
11.9			107<br />
10.9			112<br />
12.1			103<br />
11.2			105<br />
11.8			109<br />
11.7			114<br />
11.6			110<br />
12.1			100<br />
The urine was a 24 hour collection and had a volume of 1250 mL.<br />
What is the analytical imprecision in the creatinine clearance determination?<br />
10 marks</p>
<h3>9.	Match the following disease states with their biochemical/other characteristics in adults</h3>
<p>a.	Carcinoid disease<br />
b.	Phaeochromocytoma<br />
c.	Gastrinoma<br />
d.	VIPoma<br />
e.	Somatostatinoma</p>
<p>Biochemical/Other Characteristics</p>
<p>B1. Fasting blood sugar of greater than 9.0mmol/L on 2 occasions, raised faecal fats<br />
B2 Pancreatic tumour with achlorhydria<br />
B3 Pancreatic tumour often associated with MEN1<br />
B4 Elevated urine 3-hydroxy 4-methoxy mandelic acid output<br />
B5 Elevated urine urine 5 –hydroxyindol acetic acid output and raised plasma chromogranin A<br />
B6 Raised plasma glucagon				2 marks each</p>
<h3>10.	A 54 year old man with chronic renal failure is admitted to AE with chest pain.   ECG changes are suggestive of a possible MI but are not conclusive.   Troponin T at 12 hours post onset of chest pain = 0.12 ug/L.  The renal registrar phones wanting to know if the patient has had an MI.</h3>
<h4><span style="font-weight: normal;">a</span>.	What do you tell him?</h4>
<h4>b.	What further investigations may help?</h4>
<p>5 marks each</p>
<div class="lightsocial_container"><a class="lightsocial_a" href="http://digg.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F&amp;title=Spring+2008+-+Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/digg.png" alt="Digg This" title="Digg This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.reddit.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F&amp;title=Spring+2008+-+Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/reddit.png" alt="Reddit This" title="Reddit This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F&amp;title=Spring+2008+-+Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/stumbleupon.png" alt="Stumble Now!" title="Stumble Now!" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://buzz.yahoo.com/buzz?targetUrl=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F&amp;headline=Spring+2008+-+Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/yahoo_buzz.png" alt="Buzz This" title="Buzz This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dzone.com/links/add.html?title=Spring+2008+-+Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dzone.png" alt="Vote on DZone" title="Vote on DZone" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.facebook.com/sharer.php?t=Spring+2008+-+Short+Answer+Questions&amp;u=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/facebook.png" alt="Share on Facebook" title="Share on Facebook" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://delicious.com/save?title=Spring+2008+-+Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/delicious.png" alt="Bookmark this on Delicious" title="Bookmark this on Delicious" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dotnetkicks.com/kick/?title=Spring+2008+-+Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetkicks.png" alt="Kick It on DotNetKicks.com" title="Kick It on DotNetKicks.com" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://dotnetshoutout.com/Submit?title=Spring+2008+-+Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetshoutout.png" alt="Shout it" title="Shout it" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F&amp;title=Spring+2008+-+Short+Answer+Questions&amp;summary=&amp;source=" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/linkedin.png" alt="Share on LinkedIn" title="Share on LinkedIn" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.technorati.com/faves?add=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/technorati.png" alt="Bookmark this on Technorati" title="Bookmark this on Technorati" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://twitter.com/home?status=Reading+http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/twitter.png" alt="Post on Twitter" title="Post on Twitter" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.google.com/buzz/post?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fspring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/google_buzz.png" alt="Google Buzz (aka. Google Reader)" title="Google Buzz (aka. Google Reader)" /></a>&nbsp;&nbsp;</div>]]></content:encoded>
			<wfw:commentRss>http://www.wmtc.org.uk/2008/09/spring-2008-short-answer-questions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Year 1 &#8211; SAQ PAPER &#8211; Friday 27th June 2008</title>
		<link>http://www.wmtc.org.uk/2008/09/year-1-saq-paper-friday-27th-june-2008/</link>
		<comments>http://www.wmtc.org.uk/2008/09/year-1-saq-paper-friday-27th-june-2008/#comments</comments>
		<pubDate>Mon, 22 Sep 2008 20:03:08 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[2008]]></category>
		<category><![CDATA[Past Exam Papers]]></category>

		<guid isPermaLink="false">http://www.wmtc.org.uk/?p=157</guid>
		<description><![CDATA[Module 1 The following biochemistry results were obtained from an adult hypertensive patient                          Serum                              Urine Sodium           145 mmol/l      Potassium       1.7 mmol/L                     Potassium  22 mmol/L [...]]]></description>
			<content:encoded><![CDATA[<p><!--StartFragment--></p>
<p class="MsoNormal"><strong><span style="text-decoration: underline;">Module 1</span></strong></p>
<ol type="1">
<li class="MsoNormal"><strong>The      following biochemistry results were obtained from an adult hypertensive      patient </strong></li>
</ol>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><span lang="DE">                       Serum<span>      </span><span>      </span><span>      </span><span>      </span><span>      </span>Urine</span></p>
<p class="MsoNormal"><span lang="DE">Sodium <span>          </span>145 mmol/l<span>  </span><span>  </span><span> </span></span></p>
<p class="MsoNormal"><span lang="FR">Potassium<span>    </span><span>   </span>1.7 mmol/L<span>  </span><span>  </span><span>                 </span>Potassium<span>  </span>22 mmol/L</span></p>
<p class="MsoNormal"><span lang="DE">Chloride<span>    </span><span>      </span>86 mmol/L<span>  </span><span>  </span><span>  </span><span>  </span></span></p>
<p class="MsoNormal"><span>Bicarbonate <span>    </span>41 mmol/L</span></p>
<p class="MsoNormal"><span>Urea <span>  </span><span>             </span>3.4 mmol/L</span></p>
<p class="MsoNormal"><span>Creatinine <span>      </span>80 umol/L</span></p>
<p class="MsoNormal">Discuss the differential diagnosis and further appropriate biochemical investigations</p>
<p class="MsoNormal"><span>(10 marks)</span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><span>1<sup>o </sup>Hyperaldosteronism</span></p>
<p class="MsoNormal"><span>Cushings</span></p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span>For Hyperaldosteronism – aldosterone and renin.<span>  </span>Supine at 9am and Standing at 12 noon may help distinguish Conns from Bilateral Adrenal Hyperplasia</span></p>
<p class="MsoNormal"><span><span>        </span>For Cushings possible first line tests include</span></p>
<p class="MsoNormal"><span>– Overnight dexamethasone suppression test</span></p>
<p class="MsoNormal"><span><span>        </span><span>        </span><span>        </span>- Diurnal variation</span></p>
<p class="MsoNormal"><span><span>        </span><span>        </span><span>        </span>- 24 hour urine free cortisol<span>        </span></span></p>
<p class="MsoNormal"><span><span>        </span>Progressing to low and high dose dexamethasone suppression tests</span></p>
<p class="MsoNormal"> </p>
<ol type="1">
<li class="MsoNormal"><strong>List      five causes of short stature in children.</strong><span><strong>            </strong></span><span><strong>            </strong></span><span><strong>            </strong></span><span><strong>(2 marks each)</strong></span></li>
</ol>
<p class="MsoNormal"><span>Familial</span></p>
<p class="MsoNormal"><span>IUGR</span></p>
<p class="MsoNormal"><span>Russell-Silver Syndrome</span></p>
<p class="MsoNormal"><span>Growth hormone deficiency</span></p>
<p class="MsoNormal"><span>Growth hormone insensitivity syndrome</span></p>
<p class="MsoNormal"><span>Syndromic – Turner syndrome</span></p>
<p class="MsoNormal"><span>Skeletal dysplasia</span></p>
<p class="MsoNormal"><span>Chronic disease<span>  </span>- renal disease, coeliac disease, cystic fibrosis, inflammatory bowel disease, thyroid disease</span></p>
<p class="MsoNormal"><span>Psychosocial</span></p>
<p class="MsoNormal"><span>Under nutrition</span></p>
<p class="MsoNormal"> </p>
<ol type="1">
<li class="MsoNormal"><span><strong>A GP phones to ask what further investigations are needed on a 35      year old female with a serum prolactin = 1200 mU/L.</strong><span><strong>  </strong></span><strong>What advice do you give? </strong></span></li>
</ol>
<p class="MsoNormal"><span>(10 marks)</span></p>
<p class="MsoNormal"><span>Clinical features:<span>  </span>oligo/amenorrhoea, infertility and galactorrhoea</span></p>
<p class="MsoNormal">Exclude macroprolactin</p>
<p class="MsoNormal">Causes of hyperprolactinaemia – stress, pregnancy, lactation, some drugs, pituitary</p>
<p class="MsoNormal"><span>tumour, hypothyroidism, chronic renal failure, ectopic secretion.</span></p>
<p class="MsoNormal"><span>Therefore, if ? pregnancy measure serum or urine hCG</span></p>
<p class="MsoNormal"><span><span>     </span>If ? chronic renal failure measure UE</span></p>
<p class="MsoNormal"><span><span>                 </span>If ? hypothyroidism measure FT4 &amp; TSH</span></p>
<p class="MsoNormal"><span><span>      </span><span>           </span>If ? pituitary tumour measure other pituitary hormones &amp; cortisol <span> </span>and consider referral for imaging</span></p>
<ol type="1">
<li class="MsoNormal"><span><strong>Alkaline phosphatase activity is measured using para-nitrophenyl      phosphate (PNP) – molecular weight 371.</strong><span><strong>  </strong></span><strong>200 uL of substrate (255 mg in 5mL) are added to 3mL of      diethanolamine buffer at pH 9.8 to which 25 uL of serum has already been      added.</strong></span></li>
</ol>
<p class="MsoNormal"><span>Calculate the final molar concentration of substrate in the final reaction mixture.</span></p>
<p class="MsoNormal"><span>(10 marks)</span></p>
<p class="MsoNormal">Molarity of substrate prior to addition</p>
<p class="MsoNormal"><span>255mg in 5mL = (0.255*1000)/(371*5) = 0.1374M </span></p>
<p class="MsoNormal">Molarity of substrate after addition</p>
<p class="MsoNormal"><span>200uL of 0.1374M substrate added to total volume 3.225mL</span></p>
<p class="MsoNormal"><span>Therefore final molarity = 0.1374*200&#215;10<sup>-3</sup>/3.225 = 8.52&#215;10<sup>-3</sup> mole/L </span></p>
<ol type="1">
<li class="MsoNormal"><span><strong>A 57 year old woman known to have hypercalcaemia had the following      serum biochemistry results:</strong><strong></strong></span></li>
</ol>
<p class="MsoNormal"><span>Calcium 2.82 mmol/L</span></p>
<p class="MsoNormal"><span>Phosphate 0.85 mmol/L</span></p>
<p class="MsoNormal"><span>Alk Phos 98 mmol/L</span></p>
<p class="MsoNormal"><span>Albumin 40 gl/L</span></p>
<p class="MsoNormal"><span>Urea 5.7 mmol/L</span></p>
<p class="MsoNormal"><span>Creatinine 88 umol/L</span></p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span>A<span>  </span>24 hour urine collected at the same time as the blood specimen gave the following results:</span></p>
<p class="MsoNormal"><span>24 hour volume 1540 mL</span></p>
<p class="MsoNormal"><span>Creatinine 3.7 mmol/L</span></p>
<p class="MsoNormal"><span>Calcium 3.1 mmol/L</span></p>
<p class="MsoNormal">Calculate the calcium to creatinine clearance ratio.<span>     </span><span>(8 marks)</span></p>
<p class="MsoNormal">Calculation simplifies to:</p>
<p class="MsoNormal"><span>[u. calcium (mmol/L) x s. creat (umol/L/1000)] / s.calcium (mmol/L) x u.</span></p>
<p class="MsoNormal"><span>creat(mmol/L)</span></p>
<p class="MsoNormal">volume, minutes etc cancel each other out.</p>
<p class="MsoNormal">Calcium to creartinine ratio = 0.026</p>
<p class="MsoNormal">To exclude familial hypocalciuric hypercalcaemia, the clearance ratio should be &gt;0.01.<span>  </span>Comment on your results. What further test would be helpful in deciding the cause of the hypercalcaemia?<span>  </span><span>(2 marks)</span></p>
<p class="MsoNormal">Results exclude FHH. Other common causes in someone this age could be<span>     </span>primary hyperparathyroidism or malignancy. Further test &#8211; plasma PTH.</p>
<p class="MsoNormal"><strong>Module 4</strong></p>
<ol type="1">
<li class="MsoNormal"><strong>A 54yr      old man with diabetes on insulin who drinks 35 units of alcohol per week      has the following serum result</strong>s:</li>
</ol>
<p class="MsoNormal"><span lang="DE">Bilirubin<span>            </span><span>    </span><span>            </span>15 </span><span><span>m</span></span><span lang="DE">mol/L <span>            </span><span>       </span>(2 -17)</span></p>
<p class="MsoNormal"><span lang="DE">ALT<span>            </span><span>  </span><span>     </span><span>    </span><span>            </span>101 IU/L<span>            </span><span>            </span>(5 – 40)</span></p>
<p class="MsoNormal"><span lang="DE">Alk Phos<span>   </span><span>        </span><span>    </span><span>            </span>129 IU/ L<span>   </span><span>            </span><span>        </span>(30 –130)<span>            </span> </span></p>
<p class="MsoNormal"><span><span>g</span></span><span lang="DE">GT<span>            </span><span> </span><span>     </span><span>    </span><span>            </span>131 IU/L<span>            </span><span>            </span>(5 – 50)</span></p>
<p class="MsoNormal"><span lang="DE">Albumin<span>   </span><span>           </span><span>            </span><span> </span>42<span>  </span>g/L<span>            </span><span>               </span>(36 – 52</span></p>
<p class="MsoNormal"><span lang="ES">Iron<span>            </span><span>          </span><span>            </span>55 </span><span><span>m</span></span><span lang="ES">mol/L <span>            </span><span>       </span>(10 – 30) </span></p>
<p class="MsoNormal"><span lang="ES">UIBC*<span>          </span><span>          </span><span>            </span>20 </span><span><span>m</span></span><span lang="ES">mol/L<span>            </span><span>       </span>(50 &#8211; 70)</span></p>
<p class="MsoNormal"><span lang="ES">Ferritin <span>                </span><span>            </span>1093 ng/mL<span>     </span><span>             </span>(15 -300)</span></p>
<p class="MsoNormal"><span lang="ES"> </span></p>
<p class="MsoNormal"><span lang="ES">*Unsaturated iron binding capacity</span></p>
<p class="MsoNormal">List three causes for a raised serum ferritin<span>      </span><span>      </span><span>(3 marks)</span></p>
<p class="MsoNormal"><span>Iron overload syndromes (haemochromatosis)</span></p>
<p class="MsoNormal"><span>Liver disease</span></p>
<p class="MsoNormal"><span>Acute Phase Protein response (inflammation, </span></p>
<p class="MsoNormal"><span>malignancy, infection)</span></p>
<p class="MsoNormal">Calculate the percentage transferrin saturation<span>                      </span><span>(3 marks)</span></p>
<p class="MsoNormal"><span lang="ES"> </span></p>
<p class="MsoNormal"><span>% Saturation = <span>      </span>Iron </span><span><span>/</span></span><span>TIBC<span>   </span>x 100</span></p>
<p class="MsoNormal"><span>% Saturation = <span>      </span>Iron</span><span><span>/</span></span><span>(iron +UIBC)<span>   </span>x 100</span></p>
<p class="MsoNormal"><span>% Saturation = <span>      </span>73.3%</span></p>
<p class="MsoNormal"><span lang="ES">What is the most likely diagnosis?<span>      </span></span><span><span>      </span><span>      </span><span>      </span><span>(4 marks)</span><span>     </span></span></p>
<p class="MsoNormal"><span>     </span><span lang="ES">Genetic (Primary) haemochromatosis</span></p>
<p class="MsoNormal"><span lang="ES"><span>            </span><span>     </span></span><span>(Haemochromatosis – 3 marks)</span></p>
<ol type="1">
<li class="MsoNormal"><strong>Name      five types of HPLC detector </strong><span><strong>(2 marks each)</strong></span></li>
</ol>
<p class="MsoNormal">Mass spectrometry <span> </span>e.g. Vitamin D, steroids, catecholamines, immunosuppressants, drugs of abuse</p>
<p class="MsoNormal"><span>Fluorescence <span> </span>e.g. Catecholamines, amino acids, pophyrins, TPMT</span></p>
<p class="MsoNormal"><span>Electrochemical <span> </span>e.g. catecholamines, 5HIAA</span></p>
<p class="MsoNormal"><span>Ultraviolet <span> </span>e.g. HBA1c, Therapeutic drugs</span></p>
<p class="MsoNormal"><span>Refractive index e.g. Alcohols, Sugars, Fatty acids </span></p>
<ol type="1">
<li class="MsoNormal"><strong>A 65 year woman complains of epigastric pain and weight      loss.</strong><span><strong>  </strong></span><strong>Fifteen years ago she was      found to have anaemia due to vitamin B</strong><span><strong>12</strong></span><strong> deficiency. Serum antibodies to parietal cell and intrinsic factor (IF)      were negative. She had been treated with vitamin B</strong><span><strong>12</strong></span><strong> injections until vitamin B</strong><span><strong>12</strong></span><strong> replete and then was investigated with a Schilling test:</strong></li>
</ol>
<p class="MsoNormal"><span>Following an overnight fast she was given 1 mg vitamin B</span><span>12 </span><span>intramuscularly and oral </span><sup><span>57</span></sup><span>Co &amp; <sup>58</sup>Co–IF. Urine was collected for 24hours for measurement of radioisotopes and the following results were obtained:</span></p>
<p class="MsoNormal"><span>9% of <sup>57</sup>Co radiolabel excreted</span></p>
<p class="MsoNormal"><span>31% of <sup>58</sup>Co of radiolabel excreted</span></p>
<p class="MsoNormal"><strong><span>Normal response:</span></strong><span> &gt; 30% radiolabel excreted</span></p>
<p class="MsoNormal"><strong><span>Abnormal response:</span></strong><span> &lt;10% radiolabel excreted</span></p>
<p class="MsoNormal"><span>What was the original diagnosis?<span>      </span><span>      </span><span>      </span><span>      </span><span>      </span></span><span>(4 marks)</span></p>
<p class="MsoNormal">(Addison’s) Pernicious anaemia</p>
<p class="MsoNormal"><span>May have to accept gastrectomy</span></p>
<p class="MsoNormal"><span>What is the cause of the vitamin B12 deficiency in this condition?<span>      </span></span><span>(2 marks)</span></p>
<p class="MsoNormal">Atrophic gastritis/loss of intrinsic factor</p>
<p class="MsoNormal"><span>Why was the patient given 1 mg of intramuscular vitamin B</span><span>12</span><span>? <span>            </span></span><span>(2 marks)</span></p>
<p class="MsoNormal">Blocks transcobalamin binding sites ensuring that any radiolabelled</p>
<p class="MsoNormal"><span>vitamin B</span><span>12</span><span> absorbed is directly excreted via kidneys</span></p>
<p class="MsoNormal"><span>Where in the gastrointestinal tract is vitamin B12 absorbed?<span>            </span><span>            </span></span><span>(1 mark)</span></p>
<p class="MsoNormal"><strong><span>Terminal</span></strong><span> ileum</span></p>
<p class="MsoNormal"><span>(Do not accept ileum)</span></p>
<p class="MsoNormal">What is the likeliest cause of her current symptoms?<span>      </span><span>      </span><span>(1 mark)</span></p>
<p class="MsoNormal">Gastric cancer:<span>  </span>3-4 fold increased risk in PA</p>
<ol type="1">
<li class="MsoNormal"><strong>What      is the Hardy-Weinberg principle?</strong><span><strong>  </strong></span><span><strong>(2 marks)</strong></span></li>
</ol>
<p class="MsoNormal">In <a title="Population genetics" href="http://en.wikipedia.org/wiki/Population_genetics">population genetics</a>, the <strong>Hardy–Weinberg principle</strong> states that the <a title="Genotype" href="http://en.wikipedia.org/wiki/Genotype">genotype</a> frequencies in a population remain constant or are in equilibrium from generation to generation unless specific disturbing influences are introduced</p>
<p class="MsoNormal">If the observed genotype frequencies for a particular single nucleotide <span>       </span>polymorphism are:</p>
<p class="MsoNormal">AA<span>      </span><span>      </span>AB<span>      </span><span>      </span>BB</p>
<p class="MsoNormal">33<span>      </span><span>      </span>10<span>      </span><span>      </span>7</p>
<p class="MsoNormal">Calculate the expected genotype frequencies and state whether it is likely to<span>    </span>conform to the Hardy-Weinberg equilibrium<span>  </span><span>(8 marks)</span></p>
<p class="MsoNormal">A alleles<span>  </span>= (2 x 33) + 10 = 76/100 = 0.76</p>
<p class="MsoNormal">B alleles = (2 x 7) + 10 = 24/100 = 0.24</p>
<p class="MsoNormal">Expected genotypes</p>
<p class="MsoNormal">AA = (0.76)<sup>2</sup> = 0.578<span> </span></p>
<p class="MsoNormal">AB = 2 x 0.76 x 0.24 = 0.365</p>
<p class="MsoNormal">BB = (0.24)<sup>2</sup> = 0.058</p>
<p class="MsoNormal">x 50</p>
<p class="MsoNormal">AA = 29</p>
<p class="MsoNormal"><span>AB = 18</span></p>
<p class="MsoNormal"><span>BB = 3</span><span><span>      </span><span>      </span><span>      </span><span>      </span><span>      </span><span>      </span></span></p>
<p class="MsoNormal">Observed not similar to expected.<span>  </span>Unlikely to conform to H-W equilibrium</p>
<ol type="1">
<li class="MsoNormal"><strong>The      following results were found on an internal quality control sample</strong></li>
</ol>
<p class="MsoNormal"><strong>Iron (umol/L)</strong><span><strong>      </strong></span><strong>71, 67, 71, 66, 69, 71, 74, 68, 74, 70</strong></p>
<p class="MsoNormal">Calculate the mode, mean, variance, standard deviation and coefficient of variation<span>  </span><span>(2 marks each)</span></p>
<p class="MsoNormal">Mode = 71 umol/L</p>
<p class="MsoNormal">Mean = 70.1 umol/L</p>
<p class="MsoNormal">SD = 2.7 umol/L</p>
<p class="MsoNormal">Variance =<span>  </span>SD<sup>2</sup> =<span>  </span>7.2 umol/L</p>
<p class="MsoNormal">Coefficient of variation = SD/mean x 100 = 3.8%</p>
<p class="MsoNormal"><strong>Module 5</strong></p>
<p class="MsoNormal"><span><span><strong>1.</strong><span><strong>     </strong></span></span></span><span><strong>List 5 causes of polyuria</strong><span><strong>  </strong></span><span><strong>(2 marks each)</strong></span></span></p>
<p class="MsoNormal">Nephrogenic Diabetes Insipidus (including lithium, demeclocycline hypercalcaemia, hypokalaemia, chronic renal disease)</p>
<p class="MsoNormal"><span lang="FR">Cranial Diabetes Insipidus</span></p>
<p class="MsoNormal"><span lang="FR">Diabetes Mellitus</span></p>
<p class="MsoNormal"><span lang="FR">Polydypsia</span></p>
<p class="MsoNormal"><span><span><strong>2.</strong><span><strong>     </strong></span></span></span><span><strong>Define the following terms:</strong></span></p>
<p class="MsoNormal"><span>Pharmacokinetics</span></p>
<p class="MsoNormal"><span>Pharmacodynamics</span></p>
<p class="MsoNormal"><span>Pharmacogenetics</span></p>
<p class="MsoNormal"><span>Pharmacogenomics</span></p>
<p class="MsoNormal"><span>Bioavailability<span>  </span><span>(2 marks each)</span></span></p>
<p class="MsoNormal">Pharmacokinetics &#8211; what the body does to drugs (the processes of absorption, distribution, metabolism and excretion).</p>
<p class="MsoNormal"><span>Pharmacodynamics – what drugs do to the body (mechanisms of drug action &amp; biochemical/physiological effects)</span></p>
<p class="MsoNormal"><span>Pharmacogenetics – the effect of genetic variation on an individual’s response to a pharmacological agent</span></p>
<p class="MsoNormal"><span>Pharmacogenomics – changes in gene expression in response to a pharmacological agent.<span>  </span>Looks across genome to identify genes that are responsible for responses to different drugs.</span></p>
<p class="MsoNormal"><span>Bioavailability – is the dose reaching circulation divided by the dose administered</span></p>
<p class="MsoNormal"><span><span><strong>3.</strong><span><strong>     </strong></span></span></span><span><strong>A 47 year woman had recurrent and persistent duodenal ulceration despite treatment with omeprazole (proton antagonist). Two weeks after withdrawal of omperazole the following fasting results were obtaine</strong>d:</span></p>
<p class="MsoNormal">Plasma Gastrin: <span>            </span><span>            </span><span>     </span><span>            </span>1023 mU/L<span>    </span><span>            </span>(&lt;100)</p>
<p class="MsoNormal"><span>Basal gastric acid output<span>  </span><span>            </span><span>            </span>11.3 mmol/H<span>  </span><span>            </span>(0-5)</span></p>
<p class="MsoNormal"><span>Serum adjusted calcium<span>            </span><span>            </span>2.78 mmol/L<span>            </span>(2.12 -2.65)</span></p>
<p class="MsoNormal"><span>What is the most likely cause of the raised plasma gastrin?<span>        </span></span><span>(4 marks)</span></p>
<p class="MsoNormal">Gastrinoma</p>
<p class="MsoNormal"><span lang="DE">(Antral G Hyperplasia: Bonus mark)</span></p>
<p class="MsoNormal"><span>Which cells is gastrin secreted from in healthy subjects?<span>        </span><span>        </span></span><span>(2 marks)</span></p>
<p class="MsoNormal">G cells (Stomach and duodenum)</p>
<p class="MsoNormal"><span><span>      </span></span><span>Why was the omeprazole stopped prior to testing? <span>        </span><span>        </span></span><span>(2 marks)</span></p>
<p class="MsoNormal">Interferes with interpretation</p>
<p class="MsoNormal"><span>Causes achlohydria and appropriate hypergastrinaemia</span></p>
<p class="MsoNormal"><span><span>     </span><span> </span></span><span>What is potential relevance of the serum calcium result?</span><span><span>        </span><span>        </span><span>(2 marks)</span></span></p>
<p class="MsoNormal"><span><span>       </span></span><span>MEN type 1</span></p>
<p class="MsoNormal"><span><span><strong>4.</strong><span><strong>     </strong></span></span></span><span><strong>A subject was infused with a drug at the rate of 50umol/min until steady state plasma concentration of 250umol/L was reached.</strong><span><strong>  </strong></span><strong>What is the clearance of the drug?</strong><span><strong>  </strong></span><span><strong>(10 marks)</strong></span></span></p>
<p class="MsoNormal"><span> Clearance (mL/min)<span>  </span>=<span>   </span>(U (umol/L) * V(mL/min))/P (umol/L)</span></p>
<p class="MsoNormal"><span> <span>     </span>Under steady state conditions:</span></p>
<p class="MsoNormal"><span> <span>     </span>Rate of excretion (U *V) = Rate of infusion = 50 umol/min</span></p>
<p class="MsoNormal"><span> <span>     </span>Clearance (mL/min) = Rate of infusion (umol/min)/Plasma concentration (umol/<strong>mL</strong>)</span></p>
<p class="MsoNormal"><span> <span>     </span>Plasma concentration = 250 umol/L = 0.25 umol/ml</span></p>
<p class="MsoNormal"><span lang="FR"> <span>     </span>Clearance = 50/0.25 = 200 mL/min</span></p>
<p class="MsoNormal"><span lang="FR"><strong> </strong><span><span><strong>5.</strong><span><strong>     </strong></span></span></span><span><strong>The half life of serum digoxin is 38 hours.</strong><span><strong>  </strong></span><strong>What serum level would you expect to find 97 hours after a value of 3.9 µg/L in the absence of further medication?</strong><span><strong>  </strong></span><span><strong>(10 marks)</strong></span></span></span></p>
<p class="MsoNormal">I = Ioe<sup>-kt<span>    </span><span>    </span><span>    </span><span>    </span><span>    </span></sup>Where I = final concentration</p>
<p class="MsoNormal"><sup><span><span>    </span><span>    </span><span>    </span><span>    </span><span>    </span><span>    </span><span>    </span></span></sup><span>Io = initial concentration</span></p>
<p class="MsoNormal"><span style="text-decoration: underline;"><span>To find k</span></span><span><span>  </span><span>  </span><span>  </span><span>  </span><span>  </span><span>  </span>t = time</span></p>
<p class="MsoNormal"><sup><span><span>    </span><span>    </span><span>    </span><span>    </span><span>    </span><span>    </span><span>    </span></span></sup><span>k = constant</span></p>
<p class="MsoNormal"><span>I/Io = e<sup>-kt</sup></span></p>
<p class="MsoNormal">In0.5 = -kt</p>
<p class="MsoNormal">-0.693 = -kt</p>
<p class="MsoNormal">-0.693/38 = -k</p>
<p class="MsoNormal">k = 0.0182 hr<sup>-1</sup></p>
<p class="MsoNormal">To find serum level at 97hours</p>
<p class="MsoNormal">I = 3.9e<sup>(-0.0182*97)</sup></p>
<p class="MsoNormal">I = 0.67 ug/L</p>
<p class="MsoNormal"><strong>Module 6</strong></p>
<p class="MsoNormal"><span><span><strong>1.</strong><span><strong>      </strong></span></span></span><span><strong>Briefly describe the significance of IgA deficiency in testing for celiac disease. </strong><span><strong>(10 marks)</strong></span></span></p>
<p class="MsoNormal"><span>Subjects with selective IgA deficiency are at greater risk of celiac disease.<span>       </span></span></p>
<p class="MsoNormal"><span><span>In the diagnosis of celiac disease IgA anti tissue transglutaminase antibody and IgA<span>     </span>endomysial antibody are the tests of choice.<span>  </span>The potential for false negative results due to IgA deficiency therefore, arises.<span>  </span>When EMA are used total IgA should be measured on all samples to identify those with IgA deficiency.<span>  </span>TGA assays should be designed so that the<span>  </span>normal level is distinguishable from very low levels. The latter is more likely to indicate IgA deficiency <span> </span>and should trigger its measurement</span></span></p>
<p class="MsoNormal"><span><span>When IgA deficiency is found then the serological tests of choice are IgG EMA and IgG TTG.</span></span></p>
<p class="MsoNormal"><span>Some workers believe that because of the association of IgA deficiency with celiac disease that a biopsy should be considered in these individuals if there are symptoms of celiac disease. </span></p>
<p class="MsoNormal"><span><strong>2.</strong><span><strong>      </strong></span></span><strong>A 28yr year man was admitted for removal of an ingrowing toenail. He reported to</strong><span><strong>   </strong></span><strong>the admitting medical officer that he had hepatitis as a child which led to the following investigations:<br />
</strong>
</p>
<p class="MsoNormal">Hb<span>            </span><span>            </span><span>    </span>15.8 g/dL<span>            </span><span>        </span>(13.5 – 17.0)</p>
<p class="MsoNormal"><span lang="DE">Bilirubin<span>   </span><span>            </span><span>    </span>46 </span><span><span>m</span></span><span lang="DE">mol/L <span>            </span><span>     </span>(2 -17)</span></p>
<p class="MsoNormal"><span lang="DA">ALT<span>            </span><span>      </span><span>        </span>30 IU/L<span>            </span><span>            </span>(5 – 40)</span></p>
<p class="MsoNormal"><span lang="DA">AST<span>            </span><span>            </span><span>  </span>25 IU/L<span>            </span><span>            </span>(5-40)</span></p>
<p class="MsoNormal"><span lang="DA">Alk Phos<span>   </span><span>            </span><span>    </span>101 IU/ L<span>   </span><span>            </span><span>     </span>(30 –130)<span>            </span> </span></p>
<p class="MsoNormal"><span><span>g</span></span><span lang="DE">GT<span>            </span><span>      </span><span>        </span>49 IU/L<span>            </span><span>           </span>(5 – 50)</span></p>
<p class="MsoNormal"><span lang="DE">Albumin<span>    </span><span>            </span><span>   </span>36 g/L<span>            </span><span>            </span>(36 – 52)</span></p>
<p class="MsoNormal"><span lang="DE">Urine Dipstick<span>            </span><span>    </span>No bilirubin, increased Urobilinogen</span></p>
<p class="MsoNormal">What is the likely diagnosis?<span>  </span><span>(4 marks)</span></p>
<p class="MsoNormal">Gilbert’s syndrome<span>            </span><span>            </span><span>            </span><span>           </span></p>
<p class="MsoNormal"><span>(accept haemolysis)</span></p>
<p class="MsoNormal">How would confirm the diagnosis? <span>(6 marks)</span></p>
<p class="MsoNormal">Reticulocyte count (exclude haemolysis)<span>            </span>3 marks</p>
<p class="MsoNormal"><span>Others<span>            </span><span>            </span><span>            </span><span>            </span><span>            </span><span>            </span></span></p>
<p class="MsoNormal"><span>(1 mark to maximum of three for any of below)</span></p>
<p class="MsoNormal"><span>Diagnosis of exclusion</span></p>
<p class="MsoNormal"><span>Normal liver enzyme activity</span></p>
<p class="MsoNormal"><span>Unconjugated hyperbilirubinaemia or Split bilirubin</span></p>
<p class="MsoNormal"><span>Provocation tests: Nicotinic acid</span></p>
<p class="MsoNormal"><span><span>                  </span>Starvation</span></p>
<p class="MsoNormal"><span>Genetic studies</span></p>
<p class="MsoNormal"><span><span><strong>3.</strong><span><strong>              </strong></span></span></span><span><strong>Match the following diseases, syndromes or symptoms given in part 1 with one metal given </strong><strong>in part 2</strong></span></p>
<p class="MsoNormal"><span>Part1</span></p>
<p class="MsoNormal"><span>Menkes&#8217; Syndrome</span></p>
<p class="MsoNormal"><span>Keshan Syndrome</span></p>
<p class="MsoNormal"><span>Hypochromic microcytic anaemia</span></p>
<p class="MsoNormal"><span>Acrodermatitis enteropathica</span></p>
<p class="MsoNormal"><span>Basophilic stippling<span>      </span><span>      </span><span>      </span><span>      </span><span>      </span><span>      </span><span>(2 marks each)</span></span></p>
<p class="MsoNormal">Part 2.</p>
<p class="MsoNormal"><span>Iron</span></p>
<p class="MsoNormal"><span>Lead</span></p>
<p class="MsoNormal"><span>Selenium</span></p>
<p class="MsoNormal"><span>Copper</span></p>
<p class="MsoNormal"><span>Zinc</span></p>
<p class="MsoNormal"><span>Manganese</span></p>
<p class="MsoNormal"><span>Cadmium</span></p>
<p class="MsoNormal">Menkes&#8217; Syndrome &#8211; Copper</p>
<p class="MsoNormal"><span>Keshan Syndrome &#8211; Selenium</span></p>
<p class="MsoNormal"><span>Hypochromic microcytic anaemia &#8211; Iron</span></p>
<p class="MsoNormal"><span>Acrodermatitis enteropathica &#8211; Zinc</span></p>
<p class="MsoNormal"><span>Basophilic stippling<span>            </span>- Lead</span></p>
<ol type="1">
<li class="MsoNormal"><span><strong>Calculate the positive predictive value for IgA-tissue      transglutaminase antibody in a population with a prevalence of celiac disease      of 2.5% (assuming test sensitivity of 90% and specificity of 95%).</strong><span><strong>  </strong></span><span><strong>(10 marks)</strong></span></span></li>
</ol>
<p class="MsoNormal"><span><span>            </span></span><span>Assuming a population of 1 million</span></p>
<p class="MsoNormal"> </p>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="107" valign="top">
<p class="MsoNormal"><span> </span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>Diseased</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>Non-Diseased</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>Total</span></p>
</td>
</tr>
<tr>
<td width="107" valign="top">
<p class="MsoNormal"><span>Positive Test</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>22500(TP)</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>48750(FP)</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>71250</span></p>
</td>
</tr>
<tr>
<td width="107" valign="top">
<p class="MsoNormal"><span>Negative Test</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>2500(FN)</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>926250(TN)</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span> </span></p>
</td>
</tr>
<tr>
<td width="107" valign="top">
<p class="MsoNormal"><span> </span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>25000</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>975000</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span> </span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal">Where TP = true positives, FP = false positives, TN = true negatives &amp; FN = false negatives</p>
<p class="MsoNormal">Predictive value of a positive result = TP/(TP + FP) *100 = 22500/71250 = 31.6%<strong><br />
</strong></p>
<ol type="1">
<li class="MsoNormal"><span><strong>Your laboratory is now measuring a new analyte</strong><span><strong>  </strong></span><strong>- analyte Y.</strong><span><strong>  </strong></span><strong>You have determined that the      within subject variation is 5% and between subject is 7%.</strong><span><strong>  </strong></span><strong>The total CV for analyte Y is      15%.</strong><span><strong>  </strong></span><strong>What is the:</strong></span></li>
</ol>
<p class="MsoNormal">Analytical goal for imprecision<span>  </span><span>(2 marks)</span></p>
<p class="MsoNormal">0.5*CV<sub>I</sub> = analytical goal for imprecision <span>  </span>where<span>  </span>CV<sub>I</sub> = within subject imprecision</p>
<p class="MsoNormal"><span>0.5* 5 = 2.5%</span></p>
<p class="MsoNormal">Predicted standard deviation at 75 units of Y <span>(2 marks)</span></p>
<p class="MsoNormal">CV<sub>tot</sub><sup>2</sup> = CV<sub>A</sub><sup>2</sup> + CV<sub>I</sub><sup>2</sup><sub> </sub>+ CV<sub>G</sub><sup>2</sup><sub><span>    </span><span>    </span><span>    </span></sub>where CV<sub>A</sub> = analytical imprecision</p>
<p class="MsoNormal"><span>CV<sub>G</sub> = between subject imprecision</span></p>
<p class="MsoNormal"><span>CV<sub>A</sub><sup>2</sup> = CV <sub>tot</sub><sup>2</sup> – CV<sub>I</sub><sup>2 </sup>-CV<sub>G</sub><sup>2</sup><sub> </sub><span>                                        </span></span></p>
<p class="MsoNormal">CV<sub>A</sub><sup>2</sup> = 225 – 25 – 49 = 151</p>
<p class="MsoNormal">CV<sub>A = </sub>12.3%</p>
<p class="MsoNormal">%CV<sub>A</sub> = (SD/mean) * 100</p>
<p class="MsoNormal">(%CV<sub>A</sub> * mean) /100 = SD = (12.3 * 75)/100 = 9.23</p>
<p class="MsoNormal">Index of individuality <span>(3 marks)</span></p>
<p class="MsoNormal">= CV<sub>I</sub>/CV<sub>G </sub><span>  </span>= 5/7 = 0.714</p>
<p class="MsoNormal">Critical difference for assay assuming homogeneity of variance <span>(3 marks)</span></p>
<p class="MsoNormal"><span>2.77 * (CV<sub>A</sub><sup>2<span>  </span></sup>+ CV<sub>I</sub><sup>2</sup>)<sup>0.5</sup><span>  </span>= 2.77 *(12.3<sup>2</sup> + 5<sup>2</sup>)<sup>0.5</sup> = 36.7</span></p>
<p><!--EndFragment--></p>
<div class="lightsocial_container"><a class="lightsocial_a" href="http://digg.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F&amp;title=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/digg.png" alt="Digg This" title="Digg This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.reddit.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F&amp;title=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/reddit.png" alt="Reddit This" title="Reddit This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F&amp;title=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/stumbleupon.png" alt="Stumble Now!" title="Stumble Now!" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://buzz.yahoo.com/buzz?targetUrl=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F&amp;headline=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/yahoo_buzz.png" alt="Buzz This" title="Buzz This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dzone.com/links/add.html?title=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dzone.png" alt="Vote on DZone" title="Vote on DZone" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.facebook.com/sharer.php?t=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008&amp;u=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/facebook.png" alt="Share on Facebook" title="Share on Facebook" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://delicious.com/save?title=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/delicious.png" alt="Bookmark this on Delicious" title="Bookmark this on Delicious" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dotnetkicks.com/kick/?title=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetkicks.png" alt="Kick It on DotNetKicks.com" title="Kick It on DotNetKicks.com" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://dotnetshoutout.com/Submit?title=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetshoutout.png" alt="Shout it" title="Shout it" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F&amp;title=Year+1+-+SAQ+PAPER+-+Friday+27th+June+2008&amp;summary=&amp;source=" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/linkedin.png" alt="Share on LinkedIn" title="Share on LinkedIn" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.technorati.com/faves?add=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/technorati.png" alt="Bookmark this on Technorati" title="Bookmark this on Technorati" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://twitter.com/home?status=Reading+http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/twitter.png" alt="Post on Twitter" title="Post on Twitter" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.google.com/buzz/post?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fyear-1-saq-paper-friday-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/google_buzz.png" alt="Google Buzz (aka. Google Reader)" title="Google Buzz (aka. Google Reader)" /></a>&nbsp;&nbsp;</div>]]></content:encoded>
			<wfw:commentRss>http://www.wmtc.org.uk/2008/09/year-1-saq-paper-friday-27th-june-2008/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Course Assessment – Spring 2008 &#8211; Short Answer Questions</title>
		<link>http://www.wmtc.org.uk/2008/09/course-assessment-%e2%80%93-spring-2008-short-answer-questions/</link>
		<comments>http://www.wmtc.org.uk/2008/09/course-assessment-%e2%80%93-spring-2008-short-answer-questions/#comments</comments>
		<pubDate>Mon, 22 Sep 2008 19:51:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[2008]]></category>
		<category><![CDATA[Past Exam Papers]]></category>

		<guid isPermaLink="false">http://www.wmtc.org.uk/?p=155</guid>
		<description><![CDATA[Short Answer Questions.  Answer all questions.  Time allowed 1 hour   What is the absorbance of a 1cm pathlength of acetonitrile at 200nm when the percentage transmission is 80%?                                                10 marks A = 2-log10%T                                    where     A= absorbance A = 2-log1080                                                              %T= % transmission            A = [...]]]></description>
			<content:encoded><![CDATA[<p><!--StartFragment--></p>
<p class="MsoNormal" align="center">Short Answer Questions.<span>  </span>Answer all questions.<span>  </span>Time allowed 1 hour</p>
<p class="MsoNormal"> </p>
<ol type="1">
<li class="MsoNormal"><strong>What      is the absorbance of a 1cm pathlength of acetonitrile at 200nm when the      percentage transmission is 80%?</strong><span><strong>            </strong></span><span><strong>            </strong></span><span><strong>            </strong></span><span><strong>            </strong></span><span><strong>10 marks</strong></span></li>
</ol>
<p class="MsoNormal"><span>A = 2-log<sub>10</sub>%T<span>            </span><span>            </span><span>            </span>where<span>     </span>A= absorbance</span></p>
<p class="MsoNormal"><span>A = 2-log<sub>10</sub>80<span>            </span><span>            </span><span>            </span><span>            </span><span>            </span><span>  </span>%T= % transmission<span>            </span></span></p>
<p class="MsoNormal"><span>A = </span><span>0.0969</span></p>
<p class="MsoNormal"> </p>
<ol type="1">
<li class="MsoNormal"><strong>Define      1 unit of enzyme activity.</strong><span><strong>            </strong></span><span><strong>            </strong></span><span><strong>            </strong></span><span><strong>            </strong></span><span><strong>10 marks</strong></span></li>
</ol>
<p class="MsoNormal"><span> The amount of enzyme that catalyses the conversion of one micromole of substrate to product in 1 minute under appropriate conditions</span></p>
<p class="MsoNormal"><span><strong> 3. List      five biochemical abnormalities associated with rhabdomyolysis.</strong><span><strong>  </strong></span><span><strong>2 marks      each</strong></span></span></p>
<p class="MsoNormal">Raised CK<span>            </span><span>            </span><span>            </span><span>            </span><span>                  </span>Hypocalcaemia</p>
<p class="MsoNormal"><span>Hyperkalaemia<span>            </span><span>            </span><span>            </span><span>                      </span>Hyperuricaemia</span></p>
<p class="MsoNormal"><span>Hyperphosphataemia<span>            </span><span>            </span><span>            </span><span>            </span>Myoglobinuria</span></p>
<p class="MsoNormal"><span>Raised Urea/Creatinine (if renal failure)<span>                   </span>Raised LDH</span></p>
<p class="MsoNormal"><span>Abnormal LFT (if liver involvement)<span>            </span><span>              </span>Raised AST</span></p>
<p class="MsoNormal"><span>Acidosis</span></p>
<p class="MsoNormal"><span><span>           </span></span></p>
<ol type="1">
<li class="MsoNormal"><strong>A      70 kg man with severe hypomagnesaemia requires 24 mmol of magnesium      intravenously.</strong></li>
</ol>
<p class="MsoNormal"><span><strong>a.</strong><span><strong>     </strong></span></span><strong>What volume of solution containing 0.48g/2mL of anhydrous magnesium sulphate would be needed ? (Atomic Weights Mg = 24, S=32)</strong><span><strong>         </strong></span><span><strong>         </strong></span><span><strong>         </strong></span><span><strong>         </strong></span><span><strong>         </strong></span><span><strong>         </strong></span><span><strong>         </strong></span><span><strong>5 marks</strong></span></p>
<p class="MsoNormal"><span><strong>b.</strong><span><strong>     </strong></span></span><strong>What is the final calculated osmolarity of the solution if this volume is added to 500 mL of 0.9% w/v sodium chloride?</strong><span><strong>    </strong></span><span><strong>         </strong></span><span><strong>5 marks</strong></span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><span>a. <span>            </span>24 mmol of magnesium are required</span></p>
<p class="MsoNormal"><span>The stock solution contains 0.48g/2mL MgSO<sub>4</sub></span></p>
<p class="MsoNormal"><span><span>         </span><span>         </span></span><span>Molecular Weight of MgSO<sub>4</sub> = 24 + 32 + (4 x 16) = 120</span></p>
<p class="MsoNormal"><span>Therefore molar concentration of stock = 0.48/120 = 0.004 mol/2mL = 2 mmol/mL</span></p>
<p class="MsoNormal"><span><span>      </span><span>      </span>Volume containing 24 mmol of Magnesium = 24/ 2 =</span> <span>12 mL</span></p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span>b.<span>      </span><span>      </span>Final volume of solution = 512 mL</span></p>
<p class="MsoNormal"><span>500 mL of 0.9% w/v saline contains 4.5g of NaCl = 4.5/(23+35) = 0.0776 mols = 77.6 mmol NaCl</span></p>
<p class="MsoNormal"><span>12mL of MgSO<sub>4</sub> contains 24 mmol</span></p>
<p class="MsoNormal"><span>Therefore 512 mL of solution contains 24 mmol MgSO<sub>4</sub> and 77.6 mmol of sodium chloride</span></p>
<p class="MsoNormal"><span>Concentration of NaCl/L = (77.6/512)*1000 = 151.56mmol/L</span></p>
<p class="MsoNormal"><span>Concentration of MgSO<sub>4</sub> = (24/512)*1000 = 46.88 mmol/L</span></p>
<p class="MsoNormal"><span>Both compounds dissociate in solution therefore the osmolarity the solution = (2 * 151.560 + (2* 46.88) = </span><span>396.9 mmol/L</span></p>
<p class="MsoNormal"> </p>
<ol type="1">
<li class="MsoNormal"><strong>A      new screening test has been developed to detect a tumour with a prevalence      of 1 in 5000 of the population.</strong><span><strong>  </strong></span><strong>It has a diagnostic sensitivity of 95% and a specificity of 97%.</strong></li>
</ol>
<ol type="a">
<li class="MsoNormal"><strong>Calculate the diagnostic efficiency of the test</strong><span><strong>            </strong></span><span><strong>     </strong></span><span><strong>5 marks</strong><strong></strong></span></li>
<li class="MsoNormal"><strong>Calculate the negative predictive value of the test</strong><span><strong>           </strong></span><span><strong>5 marks</strong></span></li>
</ol>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span>Assuming a population of 1 million</span></p>
<p class="MsoNormal"><span> </span></p>
<table class="MsoTableGrid" border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td width="107" valign="top">
<p class="MsoNormal"><span> </span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>Diseased</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>Non-Diseased</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>Total</span></p>
</td>
</tr>
<tr>
<td width="107" valign="top">
<p class="MsoNormal"><span>Positive Test</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>190 (TP)</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>29994 (FP)</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>30184</span></p>
</td>
</tr>
<tr>
<td width="107" valign="top">
<p class="MsoNormal"><span>Negative Test</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>10 (FN)</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>969806 (TN)</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>969816</span></p>
</td>
</tr>
<tr>
<td width="107" valign="top">
<p class="MsoNormal"><span> </span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>200</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>999800</span></p>
</td>
<td width="107" valign="top">
<p class="MsoNormal"><span>1000000</span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span>a.<span>     </span></span><span>Diagnostic Efficiency = (TP+TN)/(TP+TN+FN+FP) = [(190+969806)/1000000] *100 = </span><span>97%</span></p>
<p class="MsoNormal"><span>b.<span>     </span></span><span>Negative Predictive Value = TN/(TN+FN) = [969903/(969903+10)]*100 =</span> <span>99.999%</span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><span><strong>6. A 22 year old painter and decorator presented to      his GP with a 2 week history of lethargy, malaise, headaches, nausea and      cramping abdominal pain.</strong><span><strong>  </strong></span><strong>Blood results were as follows</strong></span></p>
<p class="MsoNormal"><span>Na 140 mmol/L</span></p>
<p class="MsoNormal"><span>K 4.2 mmol/L</span></p>
<p class="MsoNormal"><span>U 5.6 mmol/L</span></p>
<p class="MsoNormal"><span>Cre 103 umol/L</span></p>
<p class="MsoNormal"><span>Alb 40 g/L</span></p>
<p class="MsoNormal"><span>ALT 24 U/L</span></p>
<p class="MsoNormal"><span>ALP 88 U/L</span></p>
<p class="MsoNormal"><span>Bili 6 umol/L</span></p>
<p class="MsoNormal"><span>Hb 9.4 g/L</span></p>
<p class="MsoNormal"><span>MCV 92 fl</span></p>
<p class="MsoNormal"><span>WCC 13.2 x10<sup>9</sup> L<sup>-1</sup></span></p>
<p class="MsoNormal"><span>Platelets 231 x10<sup>9</sup> L<sup>-1</sup></span></p>
<p class="MsoNormal"><span>Basophilic stippling of erythrocytes was noted on the blood film.</span></p>
<p class="MsoNormal"><span>a.<span>              </span></span><span>What is the most likely diagnosis?<span>   </span><span>      </span><span>      </span></span><span>4 marks</span></p>
<p class="MsoNormal"><span>b.<span>              </span></span><span>What is the mechanism behind the abnormal blood results?<span>      </span></span><span>3 marks</span></p>
<p class="MsoNormal"><span>c.<span>              </span></span><span>What management/treatment options are available?<span>      </span><span>      </span></span><span>3 marks</span></p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span><span>a.<span>                                     </span></span></span><span>Lead poisoning</span></p>
<p class="MsoNormal"><span><span>b.<span>         </span></span></span><span><span>   </span>Low Hb &#8211; lead is an electropositive metal with a high affinity for sulphydryl groups and thus inhibits sulphydryl dependent enzymes such as 5-aminolaevulinic acid dehydratase and ferrochetalase which are essential for the synthesis of haem.<span>  </span></span></p>
<p class="MsoNormal"><span>Basophilic stippling – due to inhibition of pyrimidine 5’-nucleotidase</span></p>
<p class="MsoNormal"><span><span>c.<span>                                     </span></span></span><span>Removal of patient from source of exposure</span></p>
<p class="MsoNormal"><span>Use of chelating agents if blood lead sufficiently high to warrant (e.g. sodium calcium edentate, 2,3-<span>    </span>dimercaptosuccinic acid) to form complexes with lead preventing its binding to cell constituents and allowing it to be eliminated in urine<span>            </span></span></p>
<p class="MsoNormal"><span>   </span><span>   </span></p>
<ol type="1">
<li class="MsoNormal"><span><strong>A paper describing the use of a new tumour marker      included the following data relating to the concentrations of      histologically proven disease:-</strong></span></li>
</ol>
<p class="MsoNormal"><span>Number of diseased patients (n) = 110</span></p>
<p class="MsoNormal"><span>Mean concentration of tumour marker = 80 U/L</span></p>
<p class="MsoNormal"><span>Standard error of mean = 5.5</span></p>
<p class="MsoNormal"><span>a.<span>     </span></span><span>Calculate the standard deviation of the mean<span>   </span><span>   </span></span><span>5 marks</span></p>
<p class="MsoNormal"><span>b.<span>     </span></span><span>If the reference interval for the tumour marker in non-diseased subjects is 10-15 U/L what can you conclude about the distribution of data in the diseased patients in this study? </span><span>5 marks</span></p>
<p class="MsoNormal"><span><span>a.<span>      </span></span></span><span>SE = SD/square route of n</span></p>
<p class="MsoNormal"><span><span>       </span>SD = 5.5 * square route 110 =</span> <span>57.7</span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><span>b</span>.<span>    </span><span>The data are not normally distributed as mean plus or minus 2SDs gives a negative value for the marker.<span>  </span>If normal subjects have concentrations 10-15 U/L then negative values won’t occur</span></p>
<p class="MsoNormal"><span> </span></p>
<ol type="1">
<li class="MsoNormal"><strong>One      serum and one urine sample collected from a patient for the measurement of      creatinine clearance were each assayed 10 times with the following      results:-</strong></li>
</ol>
<p class="MsoNormal">Urine Creatinine<span>   </span><span>   </span>Serum Creatinine</p>
<p class="MsoNormal">mmol/L<span>   </span><span>   </span><span>                         </span>umol/L</p>
<p class="MsoNormal">11.1<span>            </span><span>            </span><span>            </span>102</p>
<p class="MsoNormal">11.5<span>      </span><span>      </span><span>                        </span>108</p>
<p class="MsoNormal">11.9<span>            </span><span>            </span><span>            </span>107</p>
<p class="MsoNormal">10.9<span>      </span><span>      </span><span>                        </span>112</p>
<p class="MsoNormal">12.1<span>            </span><span>            </span><span>            </span>103</p>
<p class="MsoNormal">11.2<span>            </span><span>            </span><span>            </span>105</p>
<p class="MsoNormal">11.8<span>      </span><span>      </span><span>                        </span>109</p>
<p class="MsoNormal">11.7<span>            </span><span>            </span><span>            </span>114</p>
<p class="MsoNormal">11.6<span>      </span><span>      </span><span>                        </span>110</p>
<p class="MsoNormal">12.1<span>            </span><span>            </span><span>            </span>100</p>
<p class="MsoNormal">The urine was a 24 hour collection and had a volume of 1250 mL.</p>
<p class="MsoNormal">What is the analytical imprecision in the creatinine clearance determination?</p>
<p class="MsoNormal"><span>10 marks</span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><span>Approach 1</span></p>
<p class="MsoNormal">%CV = (SD/mean) *100</p>
<p class="MsoNormal">SD = sq route of<span>    </span>Σ(x-x)<sup>2</sup>/n-1<span>   </span>where x = individual value</p>
<p class="MsoNormal"><span><span>               </span><span>         </span><span>         </span><span>         </span><span>         </span><span>   </span>x = mean</span></p>
<p class="MsoNormal">However should be able to work out standard deviation on scientific calculator – suggest familiarise yourself with how to do this since it will save time<span>           </span></p>
<p class="MsoNormal">CV overall = square route of (CV<sub>serum</sub><sup>2</sup><sub> </sub>+ CV<sub>urine</sub><sup>2</sup>)</p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span><span>               </span><span>         </span>Urine Creatinine<span>         </span>Serum Creatinine</span></p>
<p class="MsoNormal"><span><span>               </span><span>         </span>mmol/L<span>         </span><span>         </span>umol/L</span></p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span>Mean<span>         </span><span>         </span>11.59<span>         </span><span>         </span><span>         </span>107<span>         </span><span>         </span><span>         </span></span></p>
<p class="MsoNormal"><span>SD<span>         </span><span>         </span>0.415<span>         </span><span>         </span><span>         </span>4.50</span></p>
<p class="MsoNormal"><span>%CV<span>         </span><span>         </span>3.58<span>         </span><span>         </span><span>         </span>4.2</span></p>
<p class="MsoNormal"><span> </span></p>
<p class="MsoNormal"><span>CV overall = square route of (4.2<sup>2</sup> + 3.58<sup>2</sup>) = </span><span>5.52%</span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">Approach 2</p>
<p class="MsoNormal">Calculate the variable part of the creatinine clearance for each point</p>
<p class="MsoNormal">Creatinine clearance = UV/ST = constant * (V/S)<span>       </span></p>
<p class="MsoNormal"><span>where<span>  </span>U = urine creatinine</span></p>
<p class="MsoNormal"><span><span>            </span>S = serum<span>  </span>creatinine</span></p>
<p class="MsoNormal"><span><span>            </span>V = volume</span></p>
<p class="MsoNormal"><span><span>            </span>T = time</span></p>
<p class="MsoNormal"> </p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" width="346">
<tbody>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>Urine creat mmol/L</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>Serum creat umol/L</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>Urine creat/Serum creat mmol/umol</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>11.1</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>102</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.109</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>11.5</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>108</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.106</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>11.9</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>107</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.111</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>10.9</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>112</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.097</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>12.1</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>103</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.117</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>11.2</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>105</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.107</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>11.8</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>109</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.108</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>11.7</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>114</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.103</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>11.6</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>110</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.105</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span>12.1</span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>100</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.121</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span> </span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>mean</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.108</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span> </span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>SD</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>0.0068</span></p>
</td>
</tr>
<tr>
<td width="91" valign="bottom">
<p class="MsoNormal"><span> </span></p>
</td>
<td width="97" valign="bottom">
<p class="MsoNormal"><span>%CV</span></p>
</td>
<td width="158" valign="bottom">
<p class="MsoNormal"><span>6.3</span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><span><strong> 9. Match      the following disease states with their biochemical/other characteristics      in adults</strong></span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal"><span>a.<span>     </span></span>Carcinoid disease</p>
<p class="MsoNormal"><span>b.<span>     </span></span>Phaeochromocytoma</p>
<p class="MsoNormal"><span>c.<span>     </span></span>Gastrinoma</p>
<p class="MsoNormal"><span>d.<span>     </span></span>VIPoma</p>
<p class="MsoNormal"><span>e.<span>     </span></span>Somatostatinoma</p>
<p class="MsoNormal">Biochemical/Other Characteristics</p>
<p class="MsoNormal">B1. Fasting blood sugar of greater than 9.0mmol/L on 2 occasions, raised faecal fats</p>
<p class="MsoNormal">B2 Pancreatic tumour with achlorhydria</p>
<p class="MsoNormal">B3 Pancreatic tumour often associated with MEN1</p>
<p class="MsoNormal">B4 Elevated urine 3-hydroxy 4-methoxy mandelic acid output</p>
<p class="MsoNormal">B5 Elevated urine urine 5 –hydroxyindol acetic acid output and raised plasma chromogranin A</p>
<p class="MsoNormal">B6 Raised plasma glucagons<span>   </span><span>   </span><span>   </span><span>   </span><span>2 marks each</span></p>
<p class="MsoNormal"> </p>
<p class="MsoNormal">a. B5</p>
<p class="MsoNormal"><span>b. B4</span></p>
<p class="MsoNormal"><span>c. B3</span></p>
<p class="MsoNormal"><span>d. B2</span></p>
<p class="MsoNormal"><span>e. B1</span></p>
<p class="MsoNormal"><span> </span></p>
<ol type="1">
<li class="MsoNormal"><strong>A      54 year old man with chronic renal failure is admitted to AE with chest      pain.</strong><span><strong>   </strong></span><strong>ECG changes are      suggestive of a possible MI but are not conclusive.</strong><span><strong>   </strong></span><strong>Troponin T at 12 hours post      onset of chest pain= 0.12 ug/L.</strong><span><strong>  </strong></span><strong>The renal registrar phones wanting to know if the patient has had      an MI.</strong></li>
</ol>
<p class="MsoNormal"><span>a.<span>     </span></span>What do you tell him?</p>
<p class="MsoNormal"><span>b.<span>     </span></span>What further investigations may help?<span>         </span><span>5 marks each</span></p>
<p class="MsoNormal"> </p>
<ol type="a">
<li class="MsoNormal">TnT      = 0.12 ug/L in the context of ischaemic chest pain would be consistent      with MI. However, raised TnT have been reported<span>  </span>in CRF in the absence of MI.<span>  </span></li>
<li class="MsoNormal">Definition      of MI requires demonstration of change in TnT concentration so repeat TnT      may help as may CK or CKMB.</li>
</ol>
<p><!--EndFragment--></p>
<div class="lightsocial_container"><a class="lightsocial_a" href="http://digg.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F&amp;title=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/digg.png" alt="Digg This" title="Digg This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.reddit.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F&amp;title=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/reddit.png" alt="Reddit This" title="Reddit This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F&amp;title=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/stumbleupon.png" alt="Stumble Now!" title="Stumble Now!" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://buzz.yahoo.com/buzz?targetUrl=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F&amp;headline=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/yahoo_buzz.png" alt="Buzz This" title="Buzz This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dzone.com/links/add.html?title=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dzone.png" alt="Vote on DZone" title="Vote on DZone" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.facebook.com/sharer.php?t=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions&amp;u=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/facebook.png" alt="Share on Facebook" title="Share on Facebook" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://delicious.com/save?title=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/delicious.png" alt="Bookmark this on Delicious" title="Bookmark this on Delicious" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dotnetkicks.com/kick/?title=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetkicks.png" alt="Kick It on DotNetKicks.com" title="Kick It on DotNetKicks.com" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://dotnetshoutout.com/Submit?title=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetshoutout.png" alt="Shout it" title="Shout it" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F&amp;title=Course+Assessment+%E2%80%93+Spring+2008+-+Short+Answer+Questions&amp;summary=&amp;source=" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/linkedin.png" alt="Share on LinkedIn" title="Share on LinkedIn" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.technorati.com/faves?add=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/technorati.png" alt="Bookmark this on Technorati" title="Bookmark this on Technorati" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://twitter.com/home?status=Reading+http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/twitter.png" alt="Post on Twitter" title="Post on Twitter" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.google.com/buzz/post?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008-short-answer-questions%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/google_buzz.png" alt="Google Buzz (aka. Google Reader)" title="Google Buzz (aka. Google Reader)" /></a>&nbsp;&nbsp;</div>]]></content:encoded>
			<wfw:commentRss>http://www.wmtc.org.uk/2008/09/course-assessment-%e2%80%93-spring-2008-short-answer-questions/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Course Assessment – Spring 2008</title>
		<link>http://www.wmtc.org.uk/2008/09/course-assessment-%e2%80%93-spring-2008/</link>
		<comments>http://www.wmtc.org.uk/2008/09/course-assessment-%e2%80%93-spring-2008/#comments</comments>
		<pubDate>Mon, 22 Sep 2008 19:44:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[2008]]></category>
		<category><![CDATA[Past Exam Papers]]></category>

		<guid isPermaLink="false">http://www.wmtc.org.uk/?p=153</guid>
		<description><![CDATA[West Midlands Training Course in Clinical Biochemistry Essay Questions. Answer 2 questions only. Time allowed 1 hour 30 minutes Outline the causes of diabetes insipidus. Discuss its diagnosis and investigation and the principles of its management. Describe the methods for the assessment of CSF xanthochromia. What are the indications for its measurement and the precautions [...]]]></description>
			<content:encoded><![CDATA[<h1>West Midlands Training Course in Clinical Biochemistry</h1>
<p>Essay Questions.</p>
<p>Answer 2 questions only.  Time allowed 1 hour 30 minutes</p>
<ol>
<li>Outline the causes of diabetes insipidus.  Discuss its diagnosis and investigation and the principles of its management.</li>
<li>Describe the methods for the assessment of CSF xanthochromia.  What are the indications for its measurement and the precautions that need to be observed in interpreting the results?</li>
<li>Critically discuss current laboratory methods for Vitamin D and PTH measurement</li>
<li>The biochemistry laboratory has a role in the management of heart failure – critically discuss.</li>
</ol>
<div class="lightsocial_container"><a class="lightsocial_a" href="http://digg.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F&amp;title=Course+Assessment+%E2%80%93+Spring+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/digg.png" alt="Digg This" title="Digg This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.reddit.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F&amp;title=Course+Assessment+%E2%80%93+Spring+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/reddit.png" alt="Reddit This" title="Reddit This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F&amp;title=Course+Assessment+%E2%80%93+Spring+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/stumbleupon.png" alt="Stumble Now!" title="Stumble Now!" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://buzz.yahoo.com/buzz?targetUrl=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F&amp;headline=Course+Assessment+%E2%80%93+Spring+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/yahoo_buzz.png" alt="Buzz This" title="Buzz This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dzone.com/links/add.html?title=Course+Assessment+%E2%80%93+Spring+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dzone.png" alt="Vote on DZone" title="Vote on DZone" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.facebook.com/sharer.php?t=Course+Assessment+%E2%80%93+Spring+2008&amp;u=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/facebook.png" alt="Share on Facebook" title="Share on Facebook" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://delicious.com/save?title=Course+Assessment+%E2%80%93+Spring+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/delicious.png" alt="Bookmark this on Delicious" title="Bookmark this on Delicious" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dotnetkicks.com/kick/?title=Course+Assessment+%E2%80%93+Spring+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetkicks.png" alt="Kick It on DotNetKicks.com" title="Kick It on DotNetKicks.com" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://dotnetshoutout.com/Submit?title=Course+Assessment+%E2%80%93+Spring+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetshoutout.png" alt="Shout it" title="Shout it" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F&amp;title=Course+Assessment+%E2%80%93+Spring+2008&amp;summary=&amp;source=" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/linkedin.png" alt="Share on LinkedIn" title="Share on LinkedIn" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.technorati.com/faves?add=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/technorati.png" alt="Bookmark this on Technorati" title="Bookmark this on Technorati" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://twitter.com/home?status=Reading+http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/twitter.png" alt="Post on Twitter" title="Post on Twitter" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.google.com/buzz/post?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2Fcourse-assessment-%25e2%2580%2593-spring-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/google_buzz.png" alt="Google Buzz (aka. Google Reader)" title="Google Buzz (aka. Google Reader)" /></a>&nbsp;&nbsp;</div>]]></content:encoded>
			<wfw:commentRss>http://www.wmtc.org.uk/2008/09/course-assessment-%e2%80%93-spring-2008/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>1st Year Essay Paper 27th June 2008</title>
		<link>http://www.wmtc.org.uk/2008/09/1st-year-essay-paper-27th-june-2008/</link>
		<comments>http://www.wmtc.org.uk/2008/09/1st-year-essay-paper-27th-june-2008/#comments</comments>
		<pubDate>Mon, 22 Sep 2008 19:42:57 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[2008]]></category>
		<category><![CDATA[Past Exam Papers]]></category>

		<guid isPermaLink="false">http://www.wmtc.org.uk/?p=151</guid>
		<description><![CDATA[MSc in Clinical Biochemistry West Midlands Training Course in Clinical Biochemistry &#38; The University of Birmingham 1st Year Essay Paper 27th June 2008 Please answer one question from each module. You will need to pass each module Time allowed 3 hours Module 1 1. Discuss the causes of hypocalcaemia. 2. Briefly describe the main causes [...]]]></description>
			<content:encoded><![CDATA[<h1>MSc in Clinical Biochemistry</h1>
<h2>West Midlands Training Course in Clinical Biochemistry &amp; The University of Birmingham</h2>
<h3>1st Year Essay Paper 27th June 2008</h3>
<p>Please answer one question from each module.</p>
<p>You will need to pass each module</p>
<p>Time allowed 3 hours</p>
<h3>Module 1</h3>
<p>1.	Discuss the causes of hypocalcaemia.</p>
<p>2.	Briefly describe the main causes of interference in immunoassays.  State what may lead you to suspect interference and how you would investigate it.</p>
<h3>Module 4</h3>
<p>1.	Describe the principles of mass spectrometry and outline the main applications of this technique in laboratory medicine.</p>
<p>2.	Critically discuss the investigation of a case of suspected acute              porphyria.</p>
<h3>Module 5</h3>
<p>1.	Discuss the sources of variability in serum enzyme activity measurements.</p>
<p>2.	A 32 year old woman presents with a blood pressure of 160/105 mmHg.  Discuss the possible pathophysiology of the hypertension and the biochemical investigation required in the patient.</p>
<h3>Module 6</h3>
<p>1.	Discuss the laboratory investigation of chronic liver disease.</p>
<p>2.	Discuss the factors that need to be considered when determining reference intervals and how you would determine the reference interval for an analyte.</p>
<div class="lightsocial_container"><a class="lightsocial_a" href="http://digg.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F&amp;title=1st+Year+Essay+Paper+27th+June+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/digg.png" alt="Digg This" title="Digg This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.reddit.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F&amp;title=1st+Year+Essay+Paper+27th+June+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/reddit.png" alt="Reddit This" title="Reddit This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F&amp;title=1st+Year+Essay+Paper+27th+June+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/stumbleupon.png" alt="Stumble Now!" title="Stumble Now!" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://buzz.yahoo.com/buzz?targetUrl=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F&amp;headline=1st+Year+Essay+Paper+27th+June+2008" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/yahoo_buzz.png" alt="Buzz This" title="Buzz This" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dzone.com/links/add.html?title=1st+Year+Essay+Paper+27th+June+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dzone.png" alt="Vote on DZone" title="Vote on DZone" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.facebook.com/sharer.php?t=1st+Year+Essay+Paper+27th+June+2008&amp;u=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/facebook.png" alt="Share on Facebook" title="Share on Facebook" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://delicious.com/save?title=1st+Year+Essay+Paper+27th+June+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/delicious.png" alt="Bookmark this on Delicious" title="Bookmark this on Delicious" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.dotnetkicks.com/kick/?title=1st+Year+Essay+Paper+27th+June+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetkicks.png" alt="Kick It on DotNetKicks.com" title="Kick It on DotNetKicks.com" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://dotnetshoutout.com/Submit?title=1st+Year+Essay+Paper+27th+June+2008&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/dotnetshoutout.png" alt="Shout it" title="Shout it" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F&amp;title=1st+Year+Essay+Paper+27th+June+2008&amp;summary=&amp;source=" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/linkedin.png" alt="Share on LinkedIn" title="Share on LinkedIn" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.technorati.com/faves?add=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/technorati.png" alt="Bookmark this on Technorati" title="Bookmark this on Technorati" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://twitter.com/home?status=Reading+http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/twitter.png" alt="Post on Twitter" title="Post on Twitter" /></a>&nbsp;&nbsp;<a class="lightsocial_a" href="http://www.google.com/buzz/post?url=http%3A%2F%2Fwww.wmtc.org.uk%2F2008%2F09%2F1st-year-essay-paper-27th-june-2008%2F" ><img class="lightsocial_img" src="http://www.wmtc.org.uk/wp-content/plugins/light-social/google_buzz.png" alt="Google Buzz (aka. Google Reader)" title="Google Buzz (aka. Google Reader)" /></a>&nbsp;&nbsp;</div>]]></content:encoded>
			<wfw:commentRss>http://www.wmtc.org.uk/2008/09/1st-year-essay-paper-27th-june-2008/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
